Abstract:Highlights • The recent advances in CO releasing nanomaterials for biological delivery of CO are reviewed. • The synthesis and properties of CORNMs, especially the release mechanisms and detection methods are discussed and listed. • A brief outlook on the future research of employing nanomaterials in CO biological release are explored and discussed. As an endogenous signaling molecule, carbon monoxide (CO) has emerged as an increasingly promising option regarding as gas therapy due to its positive pharmacological effects in various diseases. Owing to the gaseous nature and potential toxicity, it is particularly important to modulate the CO release dosages and targeted locations to elucidate the biological mechanisms of CO and facilitate its clinical applications. Based on these, diverse CO-releasing molecules (CORMs) have been developed for controlled release of CO in biological systems. However, practical applications of these CORMs are limited by several disadvantages including low stability, poor solubility, weak releasing controllability, random diffusion, and potential toxicity. In light of rapid developments and diverse advantages of nanomedicine, abundant nanomaterials releasing CO in controlled ways have been developed for therapeutic purposes across various diseases. Due to their nanoscale sizes, diversified compositions and modified surfaces, vast CO-releasing nanomaterials (CORNMs) have been constructed and exhibited controlled CO release in specific locations under various stimuli with better pharmacokinetics and pharmacodynamics. In this review, we present the recent progress in CORNMs according to their compositions. Following a concise introduction to CO therapy, CORMs and CORNMs, the representative research progress of CORNMs constructed from organic nanostructures, hybrid nanomaterials, inorganic nanomaterials, and nanocomposites is elaborated. The basic properties of these CORNMs, such as active components, CO releasing mechanisms, detection methods, and therapeutic applications, are discussed in detail and listed in a table. Finally, we explore and discuss the prospects and challenges associated with utilizing nanomaterials for biological CO release. Graphical abstract Download : Download high-res image (356KB) Download : Download full-size image

Esterase-Sensitive and Ph-Controlled Carbon Monoxide Prodrugs for Treating Systemic Inflammation.

Myleran in chronic myeloid leukaemia; chemical constitution and biological action.

CO prodrugs: a new scaffold of adamantane-fused norbornen-7-ones with tunable water solubility

Reactive Oxygen Species‐Responsive Polymeric Prodrug Nanoparticles for Selective and Effective Treatment of Inflammatory Diseases (Adv. Healthcare Mater. 29/2023)

A novel method of fleet deployment based on route risk evaluation

A Novel Precipitating-Fluorochrome-based Fluorescent Probe for Monitoring Carbon Monoxide During Drug-Induced Liver Injury.

An Enzyme-Responsive Prodrug with Inflammation-Triggered Therapeutic Drug Release Characteristics.

The construction of a near-infrared fluorescent probe with dual advantages for imaging carbon monoxide in cells and <i>in vivo</i>

X-ray-controllable release of carbon monoxide potentiates radiotherapy by ultrastable hybrid nanoreservoirs

A Near-Infrared Fluorescence Probe with a Large Stokes Shift for Detecting Carbon Monoxide in Living Cells and Mice

Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway

Dual Carbonic Anhydrase IX/XII Inhibitors and Carbon Monoxide Releasing Molecules Modulate LPS-Mediated Inflammation in Mouse Macrophages

Emerging Delivery Strategies of Carbon Monoxide for Therapeutic Applications: from CO Gas to CO Releasing Nanomaterials

Carbon Monoxide: Endogenous Production, Physiological Functions, and Pharmacological Applications.

Metal-Free CO Prodrugs Activated by Molecular Oxygen Protect against Doxorubicin-Induced Cardiomyopathy in Mice

Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years

Patient satisfaction with anaesthesia care: development of a psychometric questionnaire and benchmarking among six hospitals in Switzerland and Austria.

Recent advances in carbon monoxide-releasing nanomaterials

Theranostic Trigger-Responsive Carbon Monoxide-Generating Microbubbles

Biological Evaluation Of 2-(4-Amino-Phenyl)-3-(3,5-Dihydroxylphenyl) Propenoic Acid

Metal-based carbon monoxide releasing molecules with promising cytotoxic properties